170 related articles for article (PubMed ID: 22346256)
1. Potential implications of Helicobacter pylori-related neutrophil-activating protein.
Kountouras J; Zavos C; Deretzi G; Gavalas E; Chatzopoulos D; Katsinelos P; Tsiaousi E; Gagalis S; Polyzos SA; Venizelos I
World J Gastroenterol; 2012 Feb; 18(5):489-90. PubMed ID: 22346256
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.
Choli-Papadopoulou T; Kottakis F; Papadopoulos G; Pendas S
World J Gastroenterol; 2011 Jun; 17(21):2585-91. PubMed ID: 21677824
[TBL] [Abstract][Full Text] [Related]
3. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica.
Li W; Minohara M; Piao H; Matsushita T; Masaki K; Matsuoka T; Isobe N; Su JJ; Ohyagi Y; Kira J
Mult Scler; 2009 Dec; 15(12):1411-21. PubMed ID: 19965522
[TBL] [Abstract][Full Text] [Related]
4. Effects of mastic gum Pistacia lentiscus var. Chia on innate cellular immune effectors.
Kottakis F; Kouzi-Koliakou K; Pendas S; Kountouras J; Choli-Papadopoulou T
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):143-9. PubMed ID: 19212203
[TBL] [Abstract][Full Text] [Related]
5. VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation.
D'Elios MM; Montecucco C; de Bernard M
Clin Chim Acta; 2007 May; 381(1):32-8. PubMed ID: 17368441
[TBL] [Abstract][Full Text] [Related]
6. The Role of
Fu HW; Lai YC
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613542
[No Abstract] [Full Text] [Related]
7. Helicobacter pylori infection and demyelinating disease of the central nervous system.
Kira JI; Isobe N
J Neuroimmunol; 2019 Apr; 329():14-19. PubMed ID: 29983199
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.
Fu HW
World J Gastroenterol; 2014 May; 20(18):5294-301. PubMed ID: 24833859
[TBL] [Abstract][Full Text] [Related]
9. Virulence factors of Helicobacter pylori.
Dundon WG; de Bernard M; Montecucco C
Int J Med Microbiol; 2001 Mar; 290(8):647-58. PubMed ID: 11310443
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.
Iankov ID; Haralambieva IH; Galanis E
Vaccine; 2011 Feb; 29(8):1710-20. PubMed ID: 21182995
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori.
Montecucco C; de Bernard M
Microbes Infect; 2003 Jul; 5(8):715-21. PubMed ID: 12814772
[TBL] [Abstract][Full Text] [Related]
12. Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer.
Long M; Luo J; Li Y; Zeng FY; Li M
World J Gastroenterol; 2009 May; 15(19):2381-8. PubMed ID: 19452583
[TBL] [Abstract][Full Text] [Related]
13. The effect of mastic gum on Helicobacter pylori: a randomized pilot study.
Dabos KJ; Sfika E; Vlatta LJ; Giannikopoulos G
Phytomedicine; 2010 Mar; 17(3-4):296-9. PubMed ID: 19879118
[TBL] [Abstract][Full Text] [Related]
14. Evodiamine Inhibits
Yang JY; Kim JB; Lee P; Kim SH
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806161
[No Abstract] [Full Text] [Related]
15. Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.
Chaudhuri S; Chowdhury A; Datta S; Mukhopadhyay AK; Chattopadhya S; Saha DR; Dhali G; Santra A; Nair GB; Bhattacharya S; Berg DE
J Gastroenterol Hepatol; 2003 Feb; 18(2):190-5. PubMed ID: 12542605
[TBL] [Abstract][Full Text] [Related]
16. Mastic gum has no effect on Helicobacter pylori load in vivo.
Bebb JR; Bailey-Flitter N; Ala'Aldeen D; Atherton JC
J Antimicrob Chemother; 2003 Sep; 52(3):522-3. PubMed ID: 12888582
[TBL] [Abstract][Full Text] [Related]
17. Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.
Loughlin MF; Ala'Aldeen DA; Jenks PJ
J Antimicrob Chemother; 2003 Feb; 51(2):367-71. PubMed ID: 12562704
[TBL] [Abstract][Full Text] [Related]
18.
Altobelli A; Bauer M; Velez K; Cover TL; Müller A
mBio; 2019 Mar; 10(2):. PubMed ID: 30890606
[TBL] [Abstract][Full Text] [Related]
19. Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein.
Iankov ID; Penheiter AR; Carlson SK; Galanis E
J Immunol Methods; 2012 Oct; 384(1-2):1-9. PubMed ID: 22750540
[TBL] [Abstract][Full Text] [Related]
20. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
